These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 33032055)

  • 1. The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years.
    Friedova L; Motyl J; Srpova B; Oechtering J; Barro C; Vodehnalova K; Andelova M; Noskova L; Fialová L; Havrdova EK; Horakova D; Benedict RH; Kuhle J; Uher T
    Mult Scler Relat Disord; 2020 Nov; 46():102534. PubMed ID: 33032055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.
    Jakimovski D; Zivadinov R; Ramanthan M; Hagemeier J; Weinstock-Guttman B; Tomic D; Kropshofer H; Fuchs TA; Barro C; Leppert D; Yaldizli Ö; Kuhle J; Benedict RH
    Mult Scler; 2020 Nov; 26(13):1670-1681. PubMed ID: 31610732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
    McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
    J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients.
    Mattioli F; Bellomi F; Stampatori C; Mariotto S; Ferrari S; Monaco S; Mancinelli C; Capra R
    J Neurol; 2020 Aug; 267(8):2245-2251. PubMed ID: 32296939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
    Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis.
    Yalachkov Y; Anschütz V; Jakob J; Schaller-Paule MA; Schäfer JH; Reiländer A; Friedauer L; Behrens M; Steffen F; Bittner S; Foerch C
    Mult Scler Relat Disord; 2022 Jul; 63():103822. PubMed ID: 35504173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study.
    Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F
    EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
    Bose G; Healy BC; Saxena S; Saleh F; Paul A; Barro C; Lokhande HA; Polgar-Turcsanyi M; Anderson M; Glanz BI; Guttmann CRG; Bakshi R; Weiner HL; Chitnis T
    Mult Scler Relat Disord; 2023 Jun; 74():104695. PubMed ID: 37060852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.
    Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A
    Mult Scler Relat Disord; 2021 Sep; 54():103090. PubMed ID: 34182224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
    Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial.
    Williams T; Tur C; Eshaghi A; Doshi A; Chan D; Binks S; Wellington H; Heslegrave A; Zetterberg H; Chataway J
    Mult Scler; 2022 Oct; 28(12):1913-1926. PubMed ID: 35946107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament-light concentration and real-world outcome in MS.
    Anderson V; Bentley E; Loveless S; Bianchi L; Harding KE; Wynford-Thomas RA; Joseph F; Giovannoni G; Gnanapavan S; Robertson NP; Marta M; Tallantyre EC
    J Neurol Sci; 2020 Oct; 417():117079. PubMed ID: 32781395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Neurofilament Light Chain in the Diagnostic Evaluation of Patients with Cognitive Symptoms in the Neurological Consultation of a Tertiary Center.
    Lopes das Neves P; Durães J; Silva-Spinola A; Lima M; Leitão MJ; Tábuas-Pereira M; Santana I; Baldeiras I
    J Alzheimers Dis; 2023; 95(2):391-397. PubMed ID: 37545232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort.
    van Dam M; de Jong BA; Willemse EAJ; Nauta IM; Huiskamp M; Klein M; Moraal B; de Geus-Driessen S; Geurts JJG; Uitdehaag BMJ; Teunissen CE; Hulst HE
    J Neurol; 2023 Aug; 270(8):3851-3861. PubMed ID: 37101095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
    Buchmann A; Pirpamer L; Pinter D; Voortman M; Helmlinger B; Pichler A; Maceski AM; Benkert P; Bachmaier G; Ropele S; Reindl M; Leppert D; Kuhle J; Enzinger C; Khalil M
    Eur J Neurol; 2023 May; 30(5):1389-1399. PubMed ID: 36779855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis.
    Galetta K; Deshpande C; Healy BC; Glanz B; Ziehn M; Saxena S; Paul A; Saleh F; Collins M; Gaitan-Walsh P; Castro-Mendoza P; Weiner HL; Chitnis T
    Ann Clin Transl Neurol; 2021 Mar; 8(3):631-638. PubMed ID: 33492760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
    Monreal E; Fernández-Velasco JI; García-Sánchez MI; Sainz de la Maza S; Llufriu S; Álvarez-Lafuente R; Casanova B; Comabella M; Ramió-Torrentà L; Martínez-Rodríguez JE; Brieva L; Saiz A; Eichau S; Cabrera-Maqueda JM; Villarrubia N; Espiño M; Pérez-Miralles F; Montalbán X; Tintoré M; Quiroga-Varela A; Domínguez-Mozo MI; Rodríguez-Jorge F; Chico-García JL; Lourido D; Álvarez-Cermeño JC; Masjuan J; Costa-Frossard L; Villar LM
    JAMA Neurol; 2023 Apr; 80(4):397-403. PubMed ID: 36848127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
    Uher T; McComb M; Galkin S; Srpova B; Oechtering J; Barro C; Tyblova M; Bergsland N; Krasensky J; Dwyer M; Havrdova EK; Posova H; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
    Mult Scler; 2021 Feb; 27(2):220-231. PubMed ID: 32255388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis.
    Fujimori J; Nakashima I
    J Neurol Sci; 2021 Aug; 427():117528. PubMed ID: 34098375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.